enVVeno Medical Corporation — Cash Flow Charts
6 years of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-145.7% -$9M
$-16M
Free Cash Flow↓-147.1% -$9M
$-16M
Investing Cash Flow↓-278067.8% -$35M
$-35M
Financing Cash Flow↑+1319.6% +$54M
$58M
Capex↑+825.8% +$103K
$115K
Stock-Based Comp↑+367.8% +$7M
$9M
D&A↑+58.9% +$79K
$212K
SBC Allocated Expense↑+367.8% +$7M
$9M
SBC Unrecognized Cost
—